Active Ingredient(s):Bezlotoxumab FDA Approved: * October 21, 2016 Pharm Company: *MERCK SHARP DOHME Category:Immune System
Bezlotoxumab, sold under the brand name Zinplava, is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infections.
This drug, along with actoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School. The project was then licensed to Merck Sharp & Dohme Corp for further development and commercialization.&...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion